Menu
Virtual Visit Request an Appointment ER Wait Times
Search
Back

Filter By

All Search Results

  • Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma

    Phase II Trial of Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma

  • Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma

    A Phase II study of Naxitamab added to induction Therapy for Subjects with Newly Diagnosed High Risk Neuroblastoma

  • Finding support for her family through Healthy Families Orange: Danielle's story

    Written by Cathleen Raffety

  • Marching for hope in the fight against childhood cancer: Ethan’s story

    Ethan was a happy and healthy 13-year-old who loved football and soccer. But about a year-and-a-half ago, Ethan’s parents knew something was not right with him. Ethan began to experience incredible pain in his hip, and so they began the daunting search to try and find answers to what was causing his pain. Life quickly became a flurry of emergency room visits, tests, nurses, doctors, needles, ambulance rides - all while their other kids were still at home. Ethan and his parents were sent to Arnold Palmer Hospital for Children to meet with the pediatric oncology team.

  • Smart Tips for Packing Lunch

    Healthy eating can boost a child’s energy, increase brain activity and even brighten their demeanor. Additionally, packing a nutritious lunch with your child can be fun for the both of you. A healthy lunch will give your child the midday boost they need, and will encourage healthy eating throughout the day.

  • Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours (P3BEP)

    AGCT1532 - Phase 3 Accelerated BEP: A Randomised Phase 3 Trial of Accelerated Versus Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours

  • Thank You for Signing Up

    Thank you for opting in to continue receiving communication from The Leon Pediatric Neuroscience Center of Excellence at Orlando Health Arnold Palmer Hospital for Children. As a part of our community, you’ll receive our biannual e-newsletter, keeping you informed about all the extraordinary things happening here at Orlando Health Arnold Palmer, as well as the newest advances and technologies coming on the horizon.

  • A Study Testing the Combo of Dasatinib or Imatinib to Chemo Treatment W/ Blinatumomab for Children, Adolescents, & YA W/ Ph+ or Ph-Like B-cell B-ALL

    A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

  • A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/​or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

    AAML1831 - A phase 3 randomized trial for patients with de novo AML comparing standard therapy including gemtuzumab ozogamicin GO to CPX-351 with GO, and the addition of the FLT3 inhibitor gilteritinib for patients with FLT3 mutations

  • Cool apps for kids

    “There’s an app for that.” It seems like there is an app for our every need, even the need to keep kids entertained while parents browse the grocery store aisles, families wait to be seated at a restaurant, or driving in the car from point A to B. A recent article asked the question, “Are tablets the new Nanny?”. While this may sound ridiculous, there may be some truth behind this question. Studies show that in 2011, tablet usage among kids under the age of 12 increased by 10% within 6 months. Tablets, such as the iPad and Kindle, are kids’ new accessories, an accessory many parents are thankful for.

    Are apps really beneficial for my child?

    Great question! We do not know yet if the use of tablets and smartphones encourage healthy development among young kids. There is not enough scientific research to support this claim, as researchers are still studying the benefits of apps for kids. However, the technological trends of the world in which we live in are inevitable and growing at a rapid pace. Today, over 50% of kids now have access to a smartphone or tablet, creating a large market for apps designed specifically for kids.